SEC14L3 and non-small cell lung carcinoma: Interestingly, we found that female patients were more adaptable to immunotherapy; monocytes have a potential role in affecting NSCLC immunotherapy; SEC14L3 and APCDD1L were the underlying targets affecting immunotherapy, as well as patients survival.